Product Information

METOPROLOL-HYDROCHLOROTHIAZIDE 100-25 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.4111 per EA under NDC 00378043401. Its NADAC has been published 658 times since Nov 28, 2013.

FDA first approved this application on Aug 20, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METOPROLOL-HYDROCHLOROTHIAZIDE 100-25 MG TAB

metoprolol tartrate and hydrochlorothiazide
$1.4111per EA

Strength

25; 100 mg/1; mg/1

NDC

00378043401

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

9/23/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA076792

FDA Approved

8/20/2004

TE Code

AB

On Market Since

8/20/2004

Pharmacological Classes

Adrenergic beta-Antagonists
Increased Diuresis
Thiazide Diuretic
Thiazides
beta-Adrenergic Blocker

Price Statistics

The NADAC for METOPROLOL-HYDROCHLOROTHIAZIDE 100-25 MG TAB has been published 658 times since Nov 28, 2013, and over the history we have for it it has risen 7.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1.4111 per EA
All-time high$1.6238 (Dec 15, 2021)
All-time low$0.9383 (Oct 18, 2017)
52-week high$1.4111
52-week low$1.2341
Median price$1.3910
Average price$1.3702
Largest weekly change-23.1% (Sep 21, 2016)
Weeks tracked658
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+3.3%

3M

+4.4%

6M

+9.1%

1Y

+12.2%

3Y

-4.6%

5Y

-13.1%

All

+7.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METOPROLOL-HYDROCHLOROTHIAZIDE 100-25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL-HYDROCHLOROTHIAZIDE 100-25 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $1.4111 per EA (NDC 00378043401), effective Sep 30, 2026.

How has the price of METOPROLOL-HYDROCHLOROTHIAZIDE 100-25 MG TAB changed over time?

Over the history we have for it, the NADAC for METOPROLOL-HYDROCHLOROTHIAZIDE 100-25 MG TAB has risen 7.6%. It has been tracked across 658 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for METOPROLOL-HYDROCHLOROTHIAZIDE 100-25 MG TAB?

Since Nov 28, 2013, the NADAC for METOPROLOL-HYDROCHLOROTHIAZIDE 100-25 MG TAB has ranged from a low of $0.9383 (Oct 18, 2017) to a high of $1.6238 (Dec 15, 2021), with a median of $1.3910 per EA.

Are there cheaper alternatives to METOPROLOL-HYDROCHLOROTHIAZIDE 100-25 MG TAB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as METOPROLOL-HYDROCHLOROTHIAZIDE 100-25 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures METOPROLOL-HYDROCHLOROTHIAZIDE 100-25 MG TAB?

METOPROLOL-HYDROCHLOROTHIAZIDE 100-25 MG TAB (NDC 00378043401) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.